Live Breaking News & Updates on Paratek Pharmaceuticals Daily
Stay updated with breaking news from Paratek pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Perkins Capital Management Inc. lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 70.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,700 shares of the specialty pharmaceutical company’s stock after selling 32,000 shares during the quarter. Perkins […] ....
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently weighed in on PRTK. Jefferies Financial Group cut Paratek Pharmaceuticals from a buy rating to […] ....
StockNews.com Initiates Coverage on Paratek Pharmaceuticals (NASDAQ:PRTK) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report released on Thursday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of a number of other reports. HC Wainwright reissued a neutral rating and set a $2.15 price objective on […] ....
StockNews.com assumed coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of several other research reports. HC Wainwright reiterated a neutral rating and issued a $2.15 target […] ....